Alnylam Pharmaceuticals (ALNY) Tax Rate (2009 - 2026)
Alnylam Pharmaceuticals (ALNY) posted Tax Rate of 7.07% for Q1 2026, up 124.1% on a QoQ basis from 29.31% in Q4 2025, and up 67780.0% year-over-year from N/an in Q1 2025.
Alnylam Pharmaceuticals (ALNY) Tax Rate (2009 - 2026) Analysis & Trends
Alnylam Pharmaceuticals' Tax Rate history runs 14 years deep, the most recent figure standing at 7.07% for Q1 2026.
- Quarterly Tax Rate rose 67780.0% year-over-year to 7.07% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.66% (down 2544.0% YoY) and the FY2025 annual result came in at 2.91%, down 2338.0% from the prior year.
- Tax Rate was 7.07% for Q1 2026 at Alnylam Pharmaceuticals, up from 29.31% in the prior quarter.
- Across five years, Tax Rate topped out at 56.81% in Q4 2024 and bottomed at 670.73% in Q1 2025.
- A 5-year average of 46.29% and a median of 0.99% in 2022 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2025 — Tax Rate slumped 66704 bps — and 2026, when it surged 67780 bps.
- Alnylam Pharmaceuticals' Tax Rate stood at 0.23% in 2022, then jumped by 42 bps to 0.13% in 2023, then surged by 42846 bps to 56.81% in 2024, then sank by 152 bps to 29.31% in 2025, then soared by 124 bps to 7.07% in 2026.
- Business Quant data shows ALNY's Tax Rate at 7.07% in Q1 2026, 29.31% in Q4 2025, and 4.32% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -0.34 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 5.61 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 12.29 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 17.68 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 12.51 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -13.70 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 7.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.07 |
| Mar 31, 2026 | 7.07 |
| Mar 31, 2026 | 7.07 |
| Dec 31, 2025 | -29.31 |
| Dec 31, 2025 | -29.31 |
| Dec 31, 2025 | -29.31 |
| Sep 30, 2025 | -4.32 |
| Sep 30, 2025 | -4.32 |
| Sep 30, 2025 | -4.32 |
| Jun 30, 2025 | -87.45 |
| Jun 30, 2025 | -87.45 |
| Jun 30, 2025 | -87.45 |
| Mar 31, 2025 | -670.73 |
| Mar 31, 2025 | -670.73 |
| Mar 31, 2025 | -670.73 |
| Dec 31, 2024 | 56.81 |
| Dec 31, 2024 | 56.81 |
| Dec 31, 2024 | 56.81 |
| Sep 30, 2024 | -2.68 |
| Sep 30, 2024 | -2.68 |